Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
Atrial fibrillation and coronary artery disease are commonly coexisting conditions that necessitate the use of an oral anticoagulant as well as dual antiplatelet therapy. Commonly referred to as triple oral antithrombotic therapy (TT), this helps prevent ischemic stroke and myocardial infarction but...
Enregistré dans:
Auteurs principaux: | Abdelmoniem Moustafa, Mohammad Ruzieh, Ehab Eltahawy, Saima Karim |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/744980a3a9724d1cb85acc9fb9d3f2b4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
par: Abdelmoniem Moustafa, et autres
Publié: (2020) -
Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
par: Yutao Guo, et autres
Publié: (2010) -
Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
par: Arahata M, et autres
Publié: (2018) -
Management of patients with arterial hypertension and atrial fibrillation
par: Irina E. Chazova, et autres
Publié: (2021) -
Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: a retrospective analysis versus sinus rhythm
par: Guo Y, et autres
Publié: (2011)